期刊文献+

联合应用NLR、V20和Dmean预测肺癌放射性肺炎发生——一项外部验证研究 被引量:11

Combined use of NLR, V20 and Dmean to predict radiation-induced lung injury in lung cancer patients:an external validation study
原文传递
导出
摘要 目的用已建立的中性粒细胞、淋巴细胞绝对值比值(NLR)联合双肺V20及双肺Dmean预测肺癌放疗≥3级放射性肺炎模型,对另外一批在我院接受放疗的肺癌患者进行外部验证。方法选择参与建立模型的166例肺癌患者作为内部验证集,选择2016-2018年间在我院接受调强放疗的85例肺癌患者作为外部验证集。比较2个验证集患者≥3级放射性肺炎的发生率;对NLR、V20、Dmean行Logistic多因素预测分析;利用ROC曲线分析联合应用NLR、V20和Dmean预测放射性肺炎的区分度;利用Hosmer-Lemeshow检验来评价预测模型的校准度。结果内部验证集和外部验证集患者≥3级放射性肺炎发生率分别为23.8%和22.9%。多因素预测分析结果显示内部验证集中NLR、V20、Dmean均有统计学意义(P=0.032、0.006、0.005);外部验证集中仅V20具有统计学意义(P=0.038)。模型预测放射性肺炎区分度和校准度在内部验证集和外部验证集均相近(P>0.05)。内部验证集NLR、V20、Dmean及三者联合预测的曲线下面积值分别为0.611、0.646、0.682和0.775,外部验证集相应值分别为0.544、0.702、0.658和0.754。内部验证集校准度P=2.797、0.834。外部验证集的P=2.452、0.653。结论联合应用NLR、V20和Dmean的预测模型可以较好地预测肺癌放疗患者≥3级放射性肺炎的发生,且在外部数据集中得到了验证。 Objective To externally validate the accuracy of combined use of neutrophil-lymphocyte ratio (NLR),V20,and Dmean in predicting the incidence of grade Ⅲ or higher radiation-induced lung injury (RILI) in lung cancer patients.Methods A total of 166 lung cancer patients,who participated in the model establishment were selected into the internal validation group,and 85 lung cancer patients who received intensity-modulated radiotherapy in our department between June 2016 and June 2018 were assigned into the external validation group.The incidence rate of grade 3 or higher RILI was statistically compared between the internal and external validation groups.Multivariate logistic analysis was performed for NLR,V20 and Dmean.The discrimination degree of the predictive model was evaluated by using ROC curve in combination with NLR,V20 and Dmean.The calibration degree of the predictive model was assessed by Hosmer-Lemeshow test.Results The incidence rate of grade 3 or higher RILI in the internal and external validation groups was 23.8% and 22.9%.Multivariate logistic analysis demonstrated that NLR,V20 and Dmean significantly differed in the internal validation group (P=0.032,0.006 and 0.005).However,only V20 significantly differed in the external validation group (P=0.038).The discrimination and calibration degree of RILI was almost consistent between the internal and external validation groups (both P>0.05).The area under the curve (AUC) predicted by NLR,V20,Dmean and the combination of three indexes were 0.611,0.646,0.682 and 0.775 in the internal validation group,and 0.544,0.702,0.658 and 0.754 in the external validation group,respectively.The calibration degree in the internal validation group was P=2.797 and 0.834,P=2.452 and 0.653 in the external validation group.Conclusion Combined application of NLR,V20 and Dmean can accurately predict the incidence of grade Ⅲ or higher RILI in lung can cancer patients,which has been validated by external dataset.
作者 潘闻燕 孔伟 王艳阳 海平 白雪红 拜周兰 陆海洋 赵仁 Pan Wenyan;Kong Wei;Wang Yanyyang;Hai Ping;Bai Xuehong;Bai Zhoulan;Lu Haiyang;Zhao Ren(Clinical Cancer Research Center of Ningxia,Yinchuan 750004,China)
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2019年第6期417-420,共4页 Chinese Journal of Radiation Oncology
关键词 肺肿瘤/调强放射疗法 放射性肺炎 模型参数 Lung neoplasm/intensity-modulated radiotherapy Radiation-induced lung injury Model parameter
  • 相关文献

参考文献2

二级参考文献32

  • 1王颖杰,王绿化,冯勤付,陈东福,张宏兴,肖泽芬,周宗玫,欧广飞,赵路军,章众,张可,殷蔚伯.肺癌三维适形放射治疗中肺和食管损伤的相关因素分析[J].中国肺癌杂志,2005,8(5):454-458. 被引量:16
  • 2Bradley JD, Paulus R, Graham MV, et al. Phase Ⅱ trial of post-operative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage Ⅱ and ⅢA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group- RTOG 9705. J Clin Oncol,2005,23:3480-3487.
  • 3Fay M, Tan A, Fisher R, et al. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys, 2005,61 : 1355-1363.
  • 4Hope A J, Lindsay PE, E1 Naqa I, et al. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys,2006,65:112-124.
  • 5Kong FM, Hayman JA, Griffith KA, et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer ( NSCLC ) : predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys,2006,65:1075-1086.
  • 6Wang S, Liao Z, Wei X, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys,2006,66: 1399- 1407.
  • 7Sekine I, Sumi M, Ito Y, et al. Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patients. Radiother Oncol,2006 ,80 :93-97.
  • 8Chang DT, Olivier KR, Morris CG, et al. The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis. Int J Radiat Oncol Biol Phys,2006,65 : 125-131.
  • 9Claude L, Perol D, Ginestet C, et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non- small-cell lung cancer:clinical and dosimetric factors analysis. Radiother Oncol, 2004,71 : 175-181.
  • 10Rancati T, Ceresoli GL, Gagliardi G, et al. Factors predicting radiation pneumonitis in lung cancer patients:a retrospective study. Radiother Oucol,2003 ,67 :275-283.

共引文献15

同被引文献118

引证文献11

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部